findmyKOL

Raman Moradkhan, MD

Basic profile

Clinical Cardiac Electrophysiology

ORCIDNone on fileNPI
RegionModesto, CA · WestSpecialtyClinical Cardiac ElectrophysiologyFocusCardiology
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2015Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Raman Moradkhan is a Cardiology physician. OpenAlex indexes 18 publications with 541 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
18publications

Distinct works indexed by OpenAlex.

541citations

Total citations across indexed works.

9h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
8companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1409 E Briggsmore Ave
Modesto, CA 953552707

Telephone

209-524-1211

Registry record last updated 19 Jun 2013.

View the NPPES registry record

Industry payments

8 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

View the CMS Open Payments record ↗

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    86.6%
    Beta blocker23.2%
    Metoprolol Succinate51%Metoprolol Tartrate21%Carvedilol16%Propranolol Hcl3%Nadolol3%Atenolol2%Labetalol Hcl2%Sotalol1%
    Part D<11 patients
    Antiarrhythmic19.6%
    Flecainide Acetate47%Amiodarone Hcl42%Dofetilide4%Propafenone Hcl4%Multaq3%
    Part D191 patients

    + 18 more classes in this area

  • Blood & clotting

    9.4%
    Factor Xa inhibitor8.3%
    Eliquis74%Xarelto26%
    Part D125 patients
    P2Y12 inhibitor0.7%
    Clopidogrel67%Brilinta33%
    Part D<11 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    3.2%
    SGLT2 inhibitor1.4%
    Farxiga52%Jardiance48%
    Part D<11 patients
    Potassium supplement1.1%
    Potassium Chloride100%
    Part D25 patients

    + 2 more classes in this area

Where care is delivered (Part B)20% facility · 80% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”